sur FSD Pharma Inc.
FSD Pharma Enters Exclusive Agreement with USC for Dietary Supplement Tech
FSD Pharma Inc. has signed an exclusive option agreement with the University of Southern California (USC) to evaluate dietary supplement technology for commercialization. The agreement, effective June 11, 2024, grants FSD Pharma a 6-month period to evaluate this novel technology, with an option for extension or exclusive licensing thereafter.
The technology aims to enhance the ingredients of unbuzzd™, a blend designed to expedite alcohol metabolism, improve recovery from consumption, and boost mental alertness. FSD Pharma plans to collaborate with beverage industry leaders from Celly Nutrition to launch unbuzzd™ this summer.
"We are thrilled to sign this agreement with USC," said Zeeshan Saeed, CEO of FSD Pharma. "We look forward to exploring this technology to enhance unbuzzd™ and develop new products."
R. E.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de FSD Pharma Inc.